Zhe Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhe Li has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Sha Zhang
Department of Basic Medicine, Shaanxi University of Chinese Medicine, Xian Yang, People’s Republic of China
3 shared publicationsLiang Cao
Department of Traditional Chinese Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China
2 shared publicationsBing-Dong Sui
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration & National Clinical Research Center for Oral Diseases & Shaanxi International Joint Research Center for Oral Diseases, Center for Tissue Engineering, School of Stomatology, The Fourth Military Medical University, Xi’an, China
1 shared publication- Chen-Xi Zheng
State key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi International Joint Research Center for Oral Diseases, Center for Tissue Engineering, School of Stomatology, The Fourth Military Medical University, Xi’an, China
1 shared publication - Dingding Qu
Henan Medical Key Laboratory of Tumor Pathology and Artificial Intelligence Diagnosis, Zhengzhou Key Laboratory of Accurate Pathological Diagnosis of Intractable Tumors, Henan Engineering Research Center of Pathological Diagnostic Antibody, Department of Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, China
1 shared publication - Fang Jin
State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Orthondontics, School of Stomatology, The Fourth Military Medical University, China
1 shared publication
Latest Publications
- 20 September 2025
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 21 (8) , 2765-2780
Recipient Periodic Fasting Promotes Osteogenesis of Implanted Mesenchymal Stromal Cell Aggregates and Safeguards Diabetic Mandibular Bone Regeneration
Type 2 diabetes mellitus (T2DM) disrupts bone metabolism, exacerbating craniomaxillofacial bone loss and impairing the efficacy of regenerative therapies. While mesenchymal stromal cell (MSC)-based approaches, including MSC-derived cell aggregates (CAs), have shown promise in tissue regeneration across multiple organs, their regenerative capacity is significantly compromised in recipient diseased microenvironments. Here, using a high-fat diet (HFD)-induced T2DM murine model, this study reveals that CA implantation fails to boost osteogenesis or restore mandibular bone defects in diabetic mice due to systemic metabolic dysregulation. To address this limitation, we propose a combinatorial strategy integrating CAs with recipient periodic fasting, a metabolic intervention shown to alleviate lipidemia thus creating a beneficial condition for regeneration. Remarkably, the combined therapy enhances osteogenesis and safeguards mandibular bone regeneration in diabetic mice, evidenced by increased trabecular bone volume, reduced trabecular spacing, and elevated RUNX2 expression in defect areas. This combinatorial approach overcomes the limitations of standalone MSC therapies, highlighting the importance of addressing both local tissue repair and systemic metabolic dysregulation in diabetic bone regeneration. The findings propose a novel strategy integrating cellular engineering with metabolic interventions to optimize tissue regeneration in T2DM-related complications, offering translational potential for improving dental rehabilitation in diabetic patients.
- 20 September 2025
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 21 (8) , 2765-2780
Recipient Periodic Fasting Promotes Osteogenesis of Implanted Mesenchymal Stromal Cell Aggregates and Safeguards Diabetic Mandibular Bone Regeneration
Type 2 diabetes mellitus (T2DM) disrupts bone metabolism, exacerbating craniomaxillofacial bone loss and impairing the efficacy of regenerative therapies. While mesenchymal stromal cell (MSC)-based approaches, including MSC-derived cell aggregates (CAs), have shown promise in tissue regeneration across multiple organs, their regenerative capacity is significantly compromised in recipient diseased microenvironments. Here, using a high-fat diet (HFD)-induced T2DM murine model, this study reveals that CA implantation fails to boost osteogenesis or restore mandibular bone defects in diabetic mice due to systemic metabolic dysregulation. To address this limitation, we propose a combinatorial strategy integrating CAs with recipient periodic fasting, a metabolic intervention shown to alleviate lipidemia thus creating a beneficial condition for regeneration. Remarkably, the combined therapy enhances osteogenesis and safeguards mandibular bone regeneration in diabetic mice, evidenced by increased trabecular bone volume, reduced trabecular spacing, and elevated RUNX2 expression in defect areas. This combinatorial approach overcomes the limitations of standalone MSC therapies, highlighting the importance of addressing both local tissue repair and systemic metabolic dysregulation in diabetic bone regeneration. The findings propose a novel strategy integrating cellular engineering with metabolic interventions to optimize tissue regeneration in T2DM-related complications, offering translational potential for improving dental rehabilitation in diabetic patients.
- Open Access
- 5 January 2022
- Published by Taylor & Francis in All Life
- Vol. 15 (1) , 74-87
Network pharmacology and GEO database-based analysis of Sini powder in the prevention of depression among shift workers
It has been estimated that approximately 20% of employed adults worldwide are required to undertake shift work, which has led to severe public health decline and depression. Sini powder (SNP) has been shown to be a promising medicine. However, the effectiveness and mechanism of reducing the risk of depression for shift workers are still unclear. Thus, network pharmacological analysis and gene expression profiling were introduced to reveal the mechanism of SNP in the prevention of depression. First, five databases were used to collect the chemical compounds of SNP, and absorption, distribution, metabolism, and excretion (ADME) properties were selected to identified high-quality compounds. Second, the targets of compounds were obtained by BATMAN-TCM. And the differentially expressed genes associated with depression among shift workers were obtained using gene expression profiling (GSE98793, GSE122541). Subsequently, key targets were screened out with a protein–protein interaction (PPI) network by String. Furthermore, functional enrichment was carried out by Metascape. Molecular docking was introduced to verify the interaction between core targets and compounds. SNP reduced the risk of depression by regulating ESR2, GPER1, TNF and APOE through the estrogen pathway and NOD-like receptor signaling pathway. This study provides a scientific basis for further investigating the mechanism by which SNP prevents depression and reduces the risk of depression for shift workers.
- 5 January 2022
- Published by Taylor & Francis in All Life
- Vol. 15 (1) , 74-87
Open AccessNetwork pharmacology and GEO database-based analysis of Sini powder in the prevention of depression among shift workers
It has been estimated that approximately 20% of employed adults worldwide are required to undertake shift work, which has led to severe public health decline and depression. Sini powder (SNP) has been shown to be a promising medicine. However, the effectiveness and mechanism of reducing the risk of depression for shift workers are still unclear. Thus, network pharmacological analysis and gene expression profiling were introduced to reveal the mechanism of SNP in the prevention of depression. First, five databases were used to collect the chemical compounds of SNP, and absorption, distribution, metabolism, and excretion (ADME) properties were selected to identified high-quality compounds. Second, the targets of compounds were obtained by BATMAN-TCM. And the differentially expressed genes associated with depression among shift workers were obtained using gene expression profiling (GSE98793, GSE122541). Subsequently, key targets were screened out with a protein–protein interaction (PPI) network by String. Furthermore, functional enrichment was carried out by Metascape. Molecular docking was introduced to verify the interaction between core targets and compounds. SNP reduced the risk of depression by regulating ESR2, GPER1, TNF and APOE through the estrogen pathway and NOD-like receptor signaling pathway. This study provides a scientific basis for further investigating the mechanism by which SNP prevents depression and reduces the risk of depression for shift workers.
- 1 May 2019
- Published by Elsevier in Cancer Letters
- Vol. 450, 123-131
Metabolic reprogramming links chronic intestinal inflammation and the oncogenic transformation in colorectal tumorigenesis
- 1 May 2019
- Published by Elsevier in Cancer Letters
- Vol. 450, 123-131
Metabolic reprogramming links chronic intestinal inflammation and the oncogenic transformation in colorectal tumorigenesis
- 9 April 2018
- Published by Taylor & Francis in Journal of Asian Natural Products Research
- Vol. 21 (3) , 270-283
Anti-cancer effect of toosendanin and its underlying mechanisms
Toosendanin (TSN) is a triterpenoid purified from the medicinal herb Melia toosendan Sieb. et Zucc and has been used as an insecticide for decades. Recent studies have attracted increasing interest of TSN due to its novel anti-cancer effect in diverse cancer models. The broad spectrum anti-cancer activity suggests that TSN inhibits multiple pathways/targets that are critical for cancer cell survival and proliferation. Our recent study indicated that TSN has anti-cancer effect in glioblastoma through induction of estrogen receptor β (ERβ) and p53. This review highlights the anti-cancer efficacy of TSN and provides proof-of-principle insight into the underlying mechanisms.
- 9 April 2018
- Published by Taylor & Francis in Journal of Asian Natural Products Research
- Vol. 21 (3) , 270-283
Anti-cancer effect of toosendanin and its underlying mechanisms
Toosendanin (TSN) is a triterpenoid purified from the medicinal herb Melia toosendan Sieb. et Zucc and has been used as an insecticide for decades. Recent studies have attracted increasing interest of TSN due to its novel anti-cancer effect in diverse cancer models. The broad spectrum anti-cancer activity suggests that TSN inhibits multiple pathways/targets that are critical for cancer cell survival and proliferation. Our recent study indicated that TSN has anti-cancer effect in glioblastoma through induction of estrogen receptor β (ERβ) and p53. This review highlights the anti-cancer efficacy of TSN and provides proof-of-principle insight into the underlying mechanisms.